ArticleBiologics : targets & therapy2013

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma.

Garry M WalshPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.